April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Novel Thermo-setting Gel Eliminates Cold Storage Requirement For Improved Ocular Surface Drug Bioavailability
Author Affiliations & Notes
  • Emi Kawaguchi
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Hidekazu Suzuki
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Mayumi Takata
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Mitsuyo Takashima
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Yutaka Kitagawa
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Kazunao Masubuchi
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Masaki Itoh
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Haruhisa Hirata
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Eiichi Shirasawa
    Sagami Research Laboratories, Wakamoto Pharmaceutical Co Ltd, Ashigarakami-gun, Japan
  • Footnotes
    Commercial Relationships  Emi Kawaguchi, Wakamoto Pharmaceutical Co Ltd (E); Hidekazu Suzuki, Wakamoto Pharmaceutical Co Ltd (E); Mayumi Takata, Wakamoto Pharmaceutical Co Ltd (E); Mitsuyo Takashima, Wakamoto Pharmaceutical Co Ltd (E); Yutaka Kitagawa, Wakamoto Pharmaceutical Co Ltd (E); Kazunao Masubuchi, Wakamoto Pharmaceutical Co Ltd (E); Masaki Itoh, Wakamoto Pharmaceutical Co Ltd (E); Haruhisa Hirata, Wakamoto Pharmaceutical Co Ltd (E); Eiichi Shirasawa, Wakamoto Pharmaceutical Co Ltd (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3243. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emi Kawaguchi, Hidekazu Suzuki, Mayumi Takata, Mitsuyo Takashima, Yutaka Kitagawa, Kazunao Masubuchi, Masaki Itoh, Haruhisa Hirata, Eiichi Shirasawa; Novel Thermo-setting Gel Eliminates Cold Storage Requirement For Improved Ocular Surface Drug Bioavailability. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3243.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The thermo-setting gel containing methyl cellulose (MC) is effective for enhancing drug bioavailability. However, this delivery system must be cold stored to permit its application as a solution. To overcome this drawback, we developed a novel thermo-setting gel, which can be stored at ambient temperature, and is readily transformed back into a solution once gelation has occurred. The dependence was determined between composition changes and rheological properties as well as pharmacokinetics.

Methods: : Effects were determined of changes in composition of each thermo-setting gel on their rheological properties. Gels were modified by using various additives such as MC, sodium citrate, hydroxyethyl cellulose, mannitol and polyvinyl pyrrolidone k25. The effects were evaluated of changes in temperature and shear stress on their viscosity using a rheometer. Time dependent ocular penetrance was evaluated of either 0.5% timolol or 1% dorzolamide in rabbits using each gel using LC or tandem LC-MS-MS.

Results: : A novel gel composition was identified whose viscosity dependence on temperature was the same as that of the conventional gel formulation. With both formulations, their viscosities were higher at 35°C than those at 20°C. At 35°C, increases in shear stress caused continuous increases in conventional gel viscosity. Similarly, the viscosity of the novel gel composition initially increased, but declined at higher stress levels. Furthermore, the pharmacokinetic profiles were comparable of 0.5% timolol and 1% dorzolamide in the novel gel and its conventional counterpart.

Conclusions: : A novel thermo-setting gel composition was developed for drug delivery of an ophthalmic solution. It has rheological properties that are different from those of the conventional thermo-setting gel. Unlike the conventional gel, after gelation only the novel gel can be transformed into a solution by gentle agitation such as shaking. The conventional gel must instead be cold stored to prevent gelation prior to its administration onto the ocular surface. Therefore, the novel thermo-setting gel is expected to improve patient drug compliance.

Keywords: intraocular pressure • quality of life 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×